Skip to content
value.today

Clementia Pharmaceuticals Inc.

🇨🇦 Dorval, Quebec, Canada, CanadaPharmaceuticalsFounded 2010
Total raised
$60 M
1 round on record
Latest round
$60 M
Jun 2015
First round on record
Jun 2015
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Clementia Pharmaceuticals Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2015$60 MNo. 1$50 to $250 million

Clementia Pharmaceuticals Inc.: Raise no. 1, Jun 2015

Investors in this round

16 investors had bought by the notice of Jul 7, 2015: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$60 M of $60 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$2,145,300
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Canada (Federal Level)

People named in the notice

  • Clarissa Desjardins · Executive Officer, Director
  • Donna Roy Grogan · Executive Officer
  • Eric P. Grinstead · Executive Officer
  • Jean-Francois P. Pariseau · Executive Officer, Director
  • Jeffrey Roy Packman · Executive Officer
  • Michael Roy Singer · Executive Officer
  • Allan P. Mandelzys · Director
  • David P. Bonita · Director
  • Francois P. Nader · Director
  • Robert P. Heft · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Leerink Partners LLC (CRD 39011) · Boston, MassachusettsSold in CA, MA, MD, NC, NY

Signed by Michael Singer, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 7, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Clementia Pharmaceuticals Inc. had no revenue when it filed its newest notice of a funding round (Jul 2015).

    SEC Form D (revenue range) · Jul 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jul 2015

Products and services#

No products or services on record: its website did not answer.

Investors#

No investor of Clementia Pharmaceuticals Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Clementia Pharmaceuticals Inc.
NameRoleNamed in
Clarissa DesjardinsExecutive officerJul 2015
Donna Roy GroganExecutive officerJul 2015
Eric P. GrinsteadExecutive officerJul 2015
Jean-Francois P. PariseauExecutive officerJul 2015
Jeffrey Roy PackmanExecutive officerJul 2015
Michael Roy SingerExecutive officerJul 2015
Allan P. MandelzysDirectorJul 2015
Clarissa DesjardinsDirectorJul 2015
David P. BonitaDirectorJul 2015
Francois P. NaderDirectorJul 2015
Jean-Francois P. PariseauDirectorJul 2015
Robert P. HeftDirectorJul 2015

About

Company in Paris, France.